VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NEUPNeuphoria Therapeutics Inc.
$4.31$23M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNEUPPrice History

NEUP logoNeuphoria Therapeutics Inc. (NEUP) Stock Price History

Historical prices from 2021 to 2026

$4.31+0.00  (+0.00%)close Jun 18
Returns
1M
-9.8%
3M
-4.6%
YTD
+12.8%
1Y
-34.9%
3Y
-47.9%
5Y
-52.4%
ATH$264.00Dec 2021-98.4%
ATL$2.12Oct 2024pre-split
Avg Vol (50D)48K/ day
52-Week Range$3.65 — $21.40
LowCurrent: $4.31High

Loading 10-year price history...

NEUP Historical Performance

1 YearTotal Return
-34.9%
Price: -34.9%
3 YearsTotal Return
-85.8%
CAGR: -47.9%
Price: -85.8%
5 YearsTotal Return
-97.6%
CAGR: -52.4%
Price: -97.6%
YTD
+12.8%

NEUP Annual Returns

Year-by-year price performance · 2021–2026

Best+32.4%2025
Worst-78.8%2024
Up years2/6
2021-14.8%
2022-62.8%
2023-64.2%
2024-78.8%
2025+32.4%
2026+8.6%
2021 annual price return
-14.8%
2022 annual price return
-62.8%
2023 annual price return
-64.2%
2024 annual price return
-78.8%
2025 annual price return
+32.4%
2026 annual price return
+8.6%
LessMore
Alpha vs S&P 500
1Y-59.9%
3Y-67.4%
5Y-64.9%

Price returns only.

Download Historical Data

1,131 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NEUP Stock Price Trajectory (2021–2026)

As of June 19, 2026, Neuphoria Therapeutics Inc. (NEUP) trades at $4.31, representing a -34.9% return over the past year. The stock has delivered a -97.6% total return over five years (-52.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $264.00 on December 16, 2021. From this peak, NEUP has corrected -98.4%, currently trading 29% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ACAD (-5.8% 1Y), INVA (+4.8% 1Y), and PRAX (+557.0% 1Y), NEUP has underperformed the peer group average. Compare NEUP vs ACAD →

NEUP Historical Price Data · from 2021

Rows 1–50 of 1,131
Date Open High Low Close Volume Change %
2026-06-184.354.353.954.31150K0.00%
2026-06-174.314.434.294.3116K-1.15%
2026-06-164.284.364.184.3667K+1.63%
2026-06-154.554.554.234.2932K-1.83%
2026-06-124.344.494.214.3743K-2.67%
2026-06-114.454.524.324.4974K+1.58%
2026-06-104.634.684.344.4267K-5.15%
2026-06-094.644.894.524.6652K-0.21%
2026-06-084.954.954.584.6764K+4.01%
2026-06-054.474.494.444.4982K-7.23%
2026-06-044.704.844.504.84128K+2.98%
2026-06-034.844.874.694.7076K-3.89%
2026-06-025.175.244.824.89105K-7.74%
2026-06-015.275.305.145.3038K-0.19%
2026-05-295.255.365.255.3120K-0.93%
2026-05-285.315.485.265.3647K-0.74%
2026-05-275.445.475.305.4015K-1.14%
2026-05-265.535.535.075.4618K-0.33%
2026-05-225.205.535.175.48134K+7.03%
2026-05-215.055.184.825.1263K+3.85%
2026-05-204.715.044.484.9351K+3.35%
2026-05-194.774.784.414.77174K-0.21%
2026-05-184.844.934.634.7838K+1.06%
2026-05-154.735.104.674.7377K-7.07%
2026-05-144.995.234.935.0921K+0.79%
2026-05-135.005.074.925.0521K+2.43%
2026-05-125.205.204.914.9335K-4.64%
2026-05-115.235.245.135.1712K-0.96%
2026-05-085.305.385.125.2236K-2.25%
2026-05-075.335.385.255.3422K-0.74%
2026-05-065.455.455.335.3828K-0.28%
2026-05-055.305.395.305.3929K+1.98%
2026-05-045.225.305.205.2910K+1.34%
2026-05-015.305.335.225.2218K-0.95%
2026-04-305.205.335.195.2729K+1.54%
2026-04-295.185.315.105.1951K+1.37%
2026-04-285.035.225.035.1212K-0.58%
2026-04-274.995.294.995.1549K+2.18%
2026-04-244.875.064.815.0430K+1.20%
2026-04-234.844.994.804.9814K+1.01%
2026-04-224.905.004.884.9334K+1.23%
2026-04-215.045.114.814.8730K-3.18%
2026-04-204.745.064.655.0350K+5.45%
2026-04-174.734.804.624.7739K+1.06%
2026-04-164.644.724.644.7211K+1.51%
2026-04-154.704.724.614.6520K-1.27%
2026-04-144.654.714.444.7122K+3.06%
2026-04-134.744.774.494.5743K-4.39%
2026-04-104.704.784.554.7859K+1.27%
2026-04-094.734.734.574.7245K+0.43%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NEUP — Frequently Asked Questions

Quick answers to the most common questions about buying NEUP stock.

How has NEUP stock performed recently?

NEUP declined -34.9% over the past year, below its 5-year annualized CAGR of -52.4%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is NEUP's all-time high price?

Neuphoria Therapeutics Inc. reached $264.00 on 2021-12-16. The 52-week high is $21.40. Current 1-year return of -34.9% places the stock further from historical peaks.

Where can I download NEUP historical price data?

This page provides NEUP daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

378 data points · sampled from 1,131